Polarean Imaging (STU:8ZF) ROCE % : -86.27% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Polarean Imaging ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Polarean Imaging's annualized ROCE % for the quarter that ended in Jun. 2023 was -86.27%.

Polarean Imaging ROCE % Historical Data

The historical data trend for Polarean Imaging's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polarean Imaging ROCE % Chart

Polarean Imaging Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-89.36

-91.53

-88.22

-67.85

-54.60

Polarean Imaging Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROCE %	Get a 7-Day Free Trial								-39.36	-52.23	-48.54	-59.60	-86.27

Polarean Imaging ROCE % Calculation

Polarean Imaging's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-13.105	/	( ( (30.559 - 1.744)	+	(21.275 - 2.087) )	/ 2 )
	=	-13.105	/	( (28.815	+	19.188)	/ 2 )
	=	-13.105	/	24.0015
	=	-54.60 %

Polarean Imaging's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	-13.554	/	( ( (21.275 - 2.087)	+	(14.49 - 2.257) )	/ 2 )
	=	-13.554	/	( ( 19.188	+	12.233 )	/ 2 )
	=	-13.554	/	15.7105
	=	-86.27 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

Polarean Imaging (STU:8ZF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Polarean Imaging ROCE % Related Terms

Thank you for viewing the detailed overview of Polarean Imaging's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Polarean Imaging (STU:8ZF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polarean Imaging PLC (STU:8ZF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

PLLWF:USA POLX:UK

Address

27-28 Eastcastle Street, London, GBR, W1W 8DH

Website

https://www.polarean.com

Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.

Polarean Imaging (STU:8ZF) Headlines

No Headlines